Nanophase reports record Q1 revenue of $8.2M, up 15% YoY; guides to >$40M for FY2022

SOLESENCE, INC.

2022-Q1 EPS reported $0.00 revenue$8,156,000

Q1 revenue $8.2M vs $7.1M prior year (+15%); Solésence revenue $5.6M (+29% YoY).
Personal Care Ingredients revenue $2.4M (+71%); API sales up 70% YoY.
18 new products shipped in Q1; 30 new hires across manufacturing, supply chain, commercial.
Record monthly revenue of ~$3.8M in March; over 1M finished goods units shipped in Q1.
Management expects 2022 revenue to exceed $40M, dependent on operational improvements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.